Home
/
MERIT MEDICAL SYSTEMS INC
/
Financials
/
Quarterly
MERIT MEDICAL SYSTEMS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MERIT MEDICAL SYSTEMS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$384.16M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$382.46M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$355.35M
Apr 24, 2025
Q3
2025
Sep 30, 2024
$339.85M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$338.00M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$323.51M
Apr 24, 2025
Q3
2024
Sep 30, 2023
$315.23M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$320.06M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$297.57M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$287.18M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$294.98M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$275.42M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$267.02M
Oct 28, 2022
Q2
2022
Jun 30, 2021
$280.33M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$248.91M
May 6, 2022
Q3
2021
Sep 30, 2020
$243.98M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$218.37M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$243.53M
May 7, 2021
Q3
2020
Sep 30, 2019
$243.05M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$255.53M
Aug 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$27.76M
Oct 30, 2025
Q3
2025
Jun 30, 2025
$32.58M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$32.58M
Jul 30, 2025
Q2
2025
Mar 31, 2025
$30.15M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$30.15M
Apr 24, 2025
Q3
2025
Mar 31, 2025
$30.15M
Oct 30, 2025
Q3
2025
Sep 30, 2024
$28.44M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$35.73M
Jul 30, 2025
Q3
2025
Jun 30, 2024
$35.73M
Oct 30, 2025
Q1
2025
Mar 31, 2024
$28.24M
Apr 24, 2025
Q3
2025
Mar 31, 2024
$28.24M
Oct 30, 2025
Q2
2025
Mar 31, 2024
$28.24M
Jul 30, 2025
Q3
2024
Sep 30, 2023
$25.83M
Oct 30, 2024
Q3
2024
Jun 30, 2023
$20.25M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$20.25M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$20.70M
Apr 30, 2024
Q2
2024
Mar 31, 2023
$20.70M
Aug 1, 2024
Q3
2024
Mar 31, 2023
$20.70M
Oct 30, 2024
Q3
2023
Sep 30, 2022
$15.27M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$15.30M
Jul 28, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$42.61M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$46.88M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$41.03M
Apr 24, 2025
Q3
2025
Sep 30, 2024
$37.26M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$45.95M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$35.92M
Apr 24, 2025
Q3
2024
Sep 30, 2023
$35.14M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$28.81M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$26.38M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$18.66M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$23.26M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$15.23M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$15.93M
Oct 28, 2022
Q2
2022
Jun 30, 2021
$8.90M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$14.19M
May 6, 2022
Q3
2021
Sep 30, 2020
$64.0K
Nov 5, 2021
Q2
2021
Jun 30, 2020
($19.00M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
$1.36M
May 7, 2021
Q3
2020
Sep 30, 2019
($2.88M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
$12.20M
Aug 6, 2020